Andrew Gregory

Delphi-2M uses diagnoses, ‘medical events’ and lifestyle factors to create forecasts for next decade and beyond

Doctors say NHS rollout not fit for purpose with fewer than half of commissioning bodies prescribing Mounjaro

About 220,000 patients expected to receive Mounjaro over three years as GPs can prescribe the drugs for the first time

Exclusive: British team exposed live cells to toxic proteins to gather rare insight into how dementia develops

Plan to increase access to NHS dentists in England ‘a complete failure’, MPs say

Research highlights link between low LDL cholesterol and reduced dementia risk, with statins offering additional protection

Semaglutide, active ingredient of Wegovy and Ozempic, found to reduce cravings and cut drinking by 40%

Using drugs approved for other conditions could dramatically speed up hunt for cure, experts say

Ever growing numbers of people find themselves unable to get NHS treatment or pay for the alternative

Analysis involving more than 85,000 people showed risk of worsening function was reduced by 22%

Researchers name 14 factors for people to address to ‘hugely’ reduce risk of developing condition

US researchers say they have uncovered potential link after tracking 130,000 people over four decades

Experts believe injections such as Wegovy could play a big role in preventing and treating the disease

Exclusive: Treatments near approval but lack of diagnostic capacity means NHS is unprepared for rollout, says report